DENVER (AP) _ BioScrip Inc. (BIOS) on Friday reported a loss of $15.4 million in its fourth quarter.
The Denver-based company said it had a loss of 14 cents per share.
The results fell short of Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 3 cents per share.
The infusion and home care services company posted revenue of $183.6 million in the period, which also did not meet Street forecasts. Three analysts surveyed by Zacks expected $188.1 million.
For the year, the company reported that its loss narrowed to $51.7 million, or 49 cents per share. Revenue was reported as $708.9 million.
The company's shares closed at $3.49. A year ago, they were trading at $2.70.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on BIOS at https://www.zacks.com/ap/BIOS